vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and CENTURY ALUMINUM CO (CENX). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $633.7M, roughly 1.3× CENTURY ALUMINUM CO). Acadia Healthcare Company, Inc. runs the higher net margin — 0.5% vs 0.3%, a 0.3% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 0.4%). Over the past eight quarters, CENTURY ALUMINUM CO's revenue compounded faster (13.8% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Century Aluminum Company is a US-based producer of primary aluminum, with aluminum plants in Kentucky, South Carolina and Iceland. It is the largest producer of primary aluminum in the United States. The company is a publicly held corporation listed on the NASDAQ. The headquarters is at One South Wacker in Chicago.
ACHC vs CENX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $633.7M |
| Net Profit | $4.5M | $1.8M |
| Gross Margin | — | 13.0% |
| Operating Margin | — | 5.2% |
| Net Margin | 0.5% | 0.3% |
| Revenue YoY | 7.5% | 0.4% |
| Net Profit YoY | -50.8% | -96.0% |
| EPS (diluted) | $0.05 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $633.7M | ||
| Q3 25 | $851.6M | $632.2M | ||
| Q2 25 | $869.2M | $628.1M | ||
| Q1 25 | $770.5M | $633.9M | ||
| Q4 24 | $774.2M | $630.9M | ||
| Q3 24 | $815.6M | $539.1M | ||
| Q2 24 | $796.0M | $560.8M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $1.8M | ||
| Q3 25 | $36.2M | $14.9M | ||
| Q2 25 | $30.1M | $-4.6M | ||
| Q1 25 | $8.4M | $29.7M | ||
| Q4 24 | $32.6M | $45.2M | ||
| Q3 24 | $68.1M | $47.3M | ||
| Q2 24 | $78.5M | $-2.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 13.0% | ||
| Q3 25 | — | 12.2% | ||
| Q2 25 | — | 5.8% | ||
| Q1 25 | — | 9.6% | ||
| Q4 24 | — | 10.5% | ||
| Q3 24 | — | 15.2% | ||
| Q2 24 | — | 3.6% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 5.2% | ||
| Q3 25 | 4.7% | 9.2% | ||
| Q2 25 | 5.8% | 3.3% | ||
| Q1 25 | 1.7% | 7.3% | ||
| Q4 24 | 4.9% | 7.8% | ||
| Q3 24 | 12.1% | 11.8% | ||
| Q2 24 | 13.4% | 1.1% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 0.3% | ||
| Q3 25 | 4.3% | 2.4% | ||
| Q2 25 | 3.5% | -0.7% | ||
| Q1 25 | 1.1% | 4.7% | ||
| Q4 24 | 4.2% | 7.2% | ||
| Q3 24 | 8.4% | 8.8% | ||
| Q2 24 | 9.9% | -0.4% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.03 | ||
| Q3 25 | $0.40 | $0.15 | ||
| Q2 25 | $0.33 | $-0.05 | ||
| Q1 25 | $0.09 | $0.29 | ||
| Q4 24 | $0.36 | $0.58 | ||
| Q3 24 | $0.74 | $0.46 | ||
| Q2 24 | $0.85 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $134.2M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $805.6M |
| Total Assets | $5.5B | $2.3B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $134.2M | ||
| Q3 25 | $118.7M | $151.4M | ||
| Q2 25 | $131.4M | $40.7M | ||
| Q1 25 | $91.2M | $44.9M | ||
| Q4 24 | $76.3M | $32.9M | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | $41.3M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $805.6M | ||
| Q3 25 | $3.1B | $741.8M | ||
| Q2 25 | $3.1B | $724.4M | ||
| Q1 25 | $3.0B | $726.3M | ||
| Q4 24 | $3.1B | $694.4M | ||
| Q3 24 | $3.0B | $628.5M | ||
| Q2 24 | $3.0B | $601.5M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $2.3B | ||
| Q3 25 | $6.4B | $2.1B | ||
| Q2 25 | $6.3B | $1.9B | ||
| Q1 25 | $6.1B | $2.0B | ||
| Q4 24 | $6.0B | $1.9B | ||
| Q3 24 | $5.9B | $2.1B | ||
| Q2 24 | $5.7B | $1.8B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $102.8M |
| Free Cash FlowOCF − Capex | — | $67.7M |
| FCF MarginFCF / Revenue | — | 10.7% |
| Capex IntensityCapex / Revenue | — | 5.5% |
| Cash ConversionOCF / Net Profit | 13.78× | 57.11× |
| TTM Free Cash FlowTrailing 4 quarters | — | $84.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $102.8M | ||
| Q3 25 | $73.2M | $2.0M | ||
| Q2 25 | $133.5M | $7.9M | ||
| Q1 25 | $11.5M | $72.3M | ||
| Q4 24 | $116.7M | $-41.4M | ||
| Q3 24 | $163.1M | $20.1M | ||
| Q2 24 | $171.1M | $11.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $67.7M | ||
| Q3 25 | $-63.0M | $-18.1M | ||
| Q2 25 | $-34.2M | $-15.9M | ||
| Q1 25 | $-163.2M | $51.1M | ||
| Q4 24 | $-86.8M | $-54.6M | ||
| Q3 24 | $-27.1M | $-2.4M | ||
| Q2 24 | $16.9M | $-5.4M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 10.7% | ||
| Q3 25 | -7.4% | -2.9% | ||
| Q2 25 | -3.9% | -2.5% | ||
| Q1 25 | -21.2% | 8.1% | ||
| Q4 24 | -11.2% | -8.7% | ||
| Q3 24 | -3.3% | -0.4% | ||
| Q2 24 | 2.1% | -1.0% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 5.5% | ||
| Q3 25 | 16.0% | 3.2% | ||
| Q2 25 | 19.3% | 3.8% | ||
| Q1 25 | 22.7% | 3.3% | ||
| Q4 24 | 26.3% | 2.1% | ||
| Q3 24 | 23.3% | 4.2% | ||
| Q2 24 | 19.4% | 3.0% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 57.11× | ||
| Q3 25 | 2.02× | 0.13× | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | 2.43× | ||
| Q4 24 | 3.58× | -0.92× | ||
| Q3 24 | 2.39× | 0.42× | ||
| Q2 24 | 2.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
CENX
| Aluminum | $566.3M | 89% |
| Alumina | $67.4M | 11% |
